Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2026-01-19 @ 9:55 AM
Study NCT ID:
NCT01341457
Status:
COMPLETED
Last Update Posted:
2019-03-01
First Post:
2011-04-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
13574
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None